NCT02544243 Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer Status UNKNOWN Phase PHASE2
NCT02542111 A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL Status UNKNOWN Phase PHASE2
NCT02537561 Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors Status WITHDRAWN Phase PHASE1
NCT02537223 Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT02535325 Methoxyamine Hydrochloride, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02535312 Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02532192 A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma Status WITHDRAWN Phase PHASE1
NCT02516813 Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy Status COMPLETED Phase PHASE1
NCT02516241 Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02513355 Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research Status UNKNOWN Phase PHASE4
NCT02513342 Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Status UNKNOWN Phase PHASE4
NCT02512692 Gemcitabine-Cisplatin-90Y TARE for Unresectable Intrahepatic Cholangiocarcinoma Status TERMINATED Phase NA
NCT02508389 A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer Status COMPLETED Phase PHASE2
NCT02508246 WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1
NCT02501954 Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol Status COMPLETED Phase PHASE3
NCT02500940 Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma Status UNKNOWN Phase PHASE3
NCT02499367 Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients Status UNKNOWN Phase PHASE2
NCT02498860 Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung Status COMPLETED Phase PHASE2
NCT02497118 Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC Status COMPLETED Phase PHASE4
NCT02495896 Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1